As of September 24, 2024, the average one-year price target for Aflac is $100.81/share. The forecasts range from a low of $84.84 to a high of $120.75. The average price target represents a decrease of ...

Aflac remains a strong dividend-growth company, with a history of increasing dividends for 41 consecutive years. Cancer insurance sales are expected to be a major catalyst for long-term growth in both ...

Fintel reports that on January 23, 2025, BMO Capital initiated coverage of Aflac (NYSE:AFL) with a Market Perform recommendation. As of December 23, 2024, the average one-year price target for Aflac ...

Aflac sells multiple life insurance products, including term life and whole life. Its term and whole life products offer riders, such as a waiver of premium and an accidental death benefit. Aflac’s ...

Aflac is a high-quality dividend growth stock that I'm pleased to own in my portfolio. The company's revenue and adjusted diluted EPS surged higher in Q1. Aflac's liquidity remains nearly double its ...

Thirty-four years running the same company: It’s not that long, cosmically speaking, and yet today’s world is in some ways unrecognizably different from 1990. The American president then was George ...

Supplemental insurance isn’t sexy. But with the right media strategy, even insurance brands can engage new (and younger) audiences. Aflac, for one, dove deep into social media last summer with its ...